Cross-source evidence timeline
Triptorelin research timeline
Follow 67 selected, directly cited source records from June 15, 2000 through November 9, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.↗
PubMed lists PMID 25990480 in Archives of gynecology and obstetrics as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 2015-05-20 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 20, 2015 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
A phase II trial with new triptorelin sustained release formulations in prostatic carcinoma.↗
PubMed lists PMID 12092661 in International urology and nephrology as Clinical Trial, Clinical Trial, Phase II, Journal Article, with publication-date metadata of 2001 (year precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2001 · year precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT07816562↗
PeptideScanner retained ClinicalTrials.gov record NCT07816562 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-09-11, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT06513962↗
PeptideScanner retained ClinicalTrials.gov record NCT06513962 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-08-31, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00066690↗
PeptideScanner retained ClinicalTrials.gov record NCT00066690 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-08-26, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT05982093↗
PeptideScanner retained ClinicalTrials.gov record NCT05982093 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-04-24, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT05896566↗
PeptideScanner retained ClinicalTrials.gov record NCT05896566 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-02-24, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00066703↗
PeptideScanner retained ClinicalTrials.gov record NCT00066703 at 2026-11-15T21:49:16.513Z. Its registry update date was 2026-02-06, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Literature metadata
A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: a French anticancer federation study.↗
PubMed lists PMID 10525370 in Gynecologic oncology as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, with publication-date metadata of 1999-11 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 1999 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer: an open-label, non-comparative, multicentre, phase III study.↗
PubMed lists PMID 19888782 in Clinical drug investigation as Clinical Trial, Phase III, Journal Article, Multicenter Study, with publication-date metadata of 2009 (year precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2009 · year precisionAdded to PeptideScanner November 15, 2026Literature metadata
Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer.↗
PubMed lists PMID 29177573 in Drugs as Journal Article, Review, with publication-date metadata of 2017-12 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 2017 · month precisionAdded to PeptideScanner November 15, 2026
Source year
2025
Clinical trials
ClinicalTrials.gov record NCT07128394↗
PeptideScanner retained ClinicalTrials.gov record NCT07128394 at 2026-11-15T21:49:16.513Z. Its registry update date was 2025-08-19, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00667069↗
PeptideScanner retained ClinicalTrials.gov record NCT00667069 at 2026-11-15T21:49:16.513Z. Its registry update date was 2025-06-05, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Literature metadata
Adolescent Gender Dysphoria in Italy: Reflections on Triptorelin, Consent, and Care.↗
PubMed lists PMID 40109078 in La Clinica terapeutica as Journal Article, Review, with publication-date metadata of 2025 Mar-Apr (source-text precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2025 Mar-Apr · source-text precisionAdded to PeptideScanner November 15, 2026Regulatory
Federal Register rule 2025-01226↗
The Federal Register published rule 2025-01226, attributed to FDA and its parent HHS department, on 2025-01-21. Its official title is “New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address,” and PeptideScanner's exact reviewed identity mapping connects the document to Triptorelin.↗
Added to PeptideScanner November 15, 2026
Source year
2024
Literature metadata
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.↗
PubMed lists PMID 22231041 in Journal of clinical oncology : official journal of the American Society of Clinical Oncology as Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2012-01-09 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 9, 2012 · day precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00702520↗
PeptideScanner retained ClinicalTrials.gov record NCT00702520 at 2026-11-15T21:49:16.513Z. Its registry update date was 2024-09-05, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT06581679↗
PeptideScanner retained ClinicalTrials.gov record NCT06581679 at 2026-11-15T21:49:16.513Z. Its registry update date was 2024-09-03, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Literature metadata
An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer.↗
PubMed lists PMID 27246172 in Advances in therapy as Journal Article, Review, with publication-date metadata of 2016-05-31 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 31, 2016 · day precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT02400801↗
PeptideScanner retained ClinicalTrials.gov record NCT02400801 at 2026-11-15T21:49:16.513Z. Its registry update date was 2024-07-10, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT06473259↗
PeptideScanner retained ClinicalTrials.gov record NCT06473259 at 2026-11-15T21:49:16.513Z. Its registry update date was 2024-06-25, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Literature metadata
Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer.↗
PubMed lists PMID 29551913 in Breast cancer (Dove Medical Press) as Journal Article, Review, with publication-date metadata of 2018-03-06 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 6, 2018 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2023
Clinical trials
ClinicalTrials.gov record NCT03169166↗
PeptideScanner retained ClinicalTrials.gov record NCT03169166 at 2026-11-15T21:49:16.513Z. Its registry update date was 2023-07-20, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026
Source year
2022
Literature metadata
Triptorelin embonate (6-month formulation).↗
PubMed lists PMID 20166771 in Drugs as Journal Article, Review, with publication-date metadata of 2010-02-12 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 12, 2010 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in…↗
PubMed lists PMID 10372696 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Journal Article, with publication-date metadata of 1999-06 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 1999 · month precisionAdded to PeptideScanner November 15, 2026
Source year
2021
Clinical trials
ClinicalTrials.gov record NCT04846218↗
PeptideScanner retained ClinicalTrials.gov record NCT04846218 at 2026-11-15T21:49:16.513Z. Its registry update date was 2021-11-18, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00104741↗
PeptideScanner retained ClinicalTrials.gov record NCT00104741 at 2026-11-15T21:49:16.513Z. Its registry update date was 2021-02-21, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026
Source year
2020
Clinical trials
ClinicalTrials.gov record NCT04659551↗
PeptideScanner retained ClinicalTrials.gov record NCT04659551 at 2026-11-15T21:49:16.513Z. Its registry update date was 2020-12-09, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03115307↗
PeptideScanner retained ClinicalTrials.gov record NCT03115307 at 2026-11-15T21:49:16.513Z. Its registry update date was 2020-01-27, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026
Source year
2019
Clinical trials
ClinicalTrials.gov record NCT04189900↗
PeptideScanner retained ClinicalTrials.gov record NCT04189900 at 2026-11-15T21:49:16.513Z. Its registry update date was 2019-12-11, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Literature metadata
[Multicentre randomized trial comparing triptorelin medical castration versus surgical castration in the treatment of locally advanced or metastatic prostate cancer].↗
PubMed lists PMID 17489325 in Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2007-04 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 2007 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
[Pharmacokinetics and pharmacodynamics of triptorelin].↗
PubMed lists PMID 16302716 in Annales d'urologie as Journal Article, Review, with publication-date metadata of 2005-10 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 2005 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
Estrogen 'add-back' and lipid profile during GnRH agonist (triptorelin) therapy.↗
PubMed lists PMID 11430944 in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics as Clinical Trial, Journal Article, with publication-date metadata of 2001-07 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 2001 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
Long-acting triptorelin for the treatment of endometriosis.↗
PubMed lists PMID 8889631 in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics as Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 1996-09 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 1996 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis.↗
PubMed lists PMID 7781864 in European journal of obstetrics, gynecology, and reproductive biology as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1995-03 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 1995 · month precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT02238366↗
PeptideScanner retained ClinicalTrials.gov record NCT02238366 at 2026-11-15T21:49:16.513Z. Its registry update date was 2019-07-25, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Literature metadata
Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study.↗
PubMed lists PMID 10099998 in Human reproduction (Oxford, England) as Clinical Trial, Journal Article, with publication-date metadata of 1999-02 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 1999 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
Triptorelin depot for the treatment of children 2 years and older with central precocious puberty.↗
PubMed lists PMID 29957076 in Expert review of clinical pharmacology as Journal Article, Review, with publication-date metadata of 2018-07-26 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 26, 2018 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2018
Literature metadata
Triptorelin in the management of prostate cancer.↗
PubMed lists PMID 23252566 in Future oncology (London, England) as Journal Article, Review, with publication-date metadata of 2013-01 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 2013 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
Triptorelin for the treatment of endometriosis.↗
PubMed lists PMID 24832495 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2014-06 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 2014 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
[Treatment of central precocious puberty with Gonadotropin-Releasing Hormone agonist (triptorelin) in girls: breast development, skeletal maturation, height and weight evolution during and after trea…↗
PubMed lists PMID 15816337 in Revue medicale de Bruxelles as Clinical Trial, Journal Article, with publication-date metadata of 2005-02 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 2005 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
Early cessation of triptorelin in in vitro fertilization: a double-blind, randomized study.↗
PubMed lists PMID 15820796 in Fertility and sterility as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2005-04 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 2005 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
[Pharmacodynamics of triptorelin].↗
PubMed lists PMID 15822863 in La Revue du praticien as Journal Article, Review, with publication-date metadata of 2005 (year precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2005 · year precisionAdded to PeptideScanner November 15, 2026Literature metadata
Anti-androgenic treatment of obsessive-compulsive disorder: an open-label clinical trial of the long-acting gonadotropin-releasing hormone analogue triptorelin.↗
PubMed lists PMID 17159461 in International clinical psychopharmacology as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-01 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 2007 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis.↗
PubMed lists PMID 17178185 in European journal of obstetrics, gynecology, and reproductive biology as Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2006-12-18 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 18, 2006 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Triptorelin embonate: a 6-month formulation for prostate cancer.↗
PubMed lists PMID 20969451 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2010-10-23 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 23, 2010 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
[Decapeptyl (triptorelin) in the treatment of endometriosis genitalis externa].↗
PubMed lists PMID 11526759 in Ginekologia polska as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2001-05 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 2001 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.↗
PubMed lists PMID 12147888 in Indian pediatrics as Clinical Trial, Journal Article, with publication-date metadata of 2002-07 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 2002 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis.↗
PubMed lists PMID 14967363 in Fertility and sterility as Clinical Trial, Clinical Trial, Phase II, Comparative Study, Journal Article, Multicenter Study, and 2 more PubMed publication types, with publication-date metadata of 2004-02 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 2004 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapept…↗
PubMed lists PMID 8839551 in Cancer as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1996-10-01 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 1, 1996 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2017
Clinical trials
ClinicalTrials.gov record NCT01467882↗
PeptideScanner retained ClinicalTrials.gov record NCT01467882 at 2026-11-15T21:49:16.513Z. Its registry update date was 2017-07-28, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Regulatory
Drugs@FDA application NDA208956↗
The official Drugs@FDA dataset lists original submission 1 for NDA 208956 with status AP dated 2017-06-29, and names triptorelin pamoate among the application record's active ingredients.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT02208986↗
PeptideScanner retained ClinicalTrials.gov record NCT02208986 at 2026-11-15T21:49:16.513Z. Its registry update date was 2017-02-06, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026
Source year
2016
Clinical trials
ClinicalTrials.gov record NCT01500863↗
PeptideScanner retained ClinicalTrials.gov record NCT01500863 at 2026-11-15T21:49:16.513Z. Its registry update date was 2016-10-26, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00659373↗
PeptideScanner retained ClinicalTrials.gov record NCT00659373 at 2026-11-15T21:49:16.513Z. Its registry update date was 2016-07-25, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026
Source year
2015
Clinical trials
ClinicalTrials.gov record NCT01160315↗
PeptideScanner retained ClinicalTrials.gov record NCT01160315 at 2026-11-15T21:49:16.513Z. Its registry update date was 2015-10-30, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT02102646↗
PeptideScanner retained ClinicalTrials.gov record NCT02102646 at 2026-11-15T21:49:16.513Z. Its registry update date was 2015-10-28, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Regulatory
Federal Register notice 2015-11003↗
The Federal Register published notice 2015-11003, attributed to FDA and its parent HHS department, on 2015-05-07. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; OVUGEL,” and PeptideScanner's exact reviewed identity mapping connects the document to Triptorelin.↗
Added to PeptideScanner November 15, 2026
Source year
2013
Clinical trials
ClinicalTrials.gov record NCT00311636↗
PeptideScanner retained ClinicalTrials.gov record NCT00311636 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-06-26, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT01732068↗
PeptideScanner retained ClinicalTrials.gov record NCT01732068 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-05-09, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT01732094↗
PeptideScanner retained ClinicalTrials.gov record NCT01732094 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-05-09, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT01764230↗
PeptideScanner retained ClinicalTrials.gov record NCT01764230 at 2026-11-15T21:49:16.513Z. Its registry update date was 2013-01-09, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026
Source year
2012
Regulatory
Federal Register rule 2012-25989↗
The Federal Register published rule 2012-25989, attributed to FDA and its parent HHS department, on 2012-10-23. Its official title is “New Animal Drugs; Approvals; Changes of Sponsor; Change of Sponsor's Name; Change of Sponsor's Address; Alfaxalone; Ivermectin and Clorsulon; Narasin; Triptorelin,” and PeptideScanner's exact reviewed identity mapping connects the document to Triptorelin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00003026↗
PeptideScanner retained ClinicalTrials.gov record NCT00003026 at 2026-11-15T21:49:16.513Z. Its registry update date was 2012-07-02, and PeptideScanner's reviewed identity mapping was triptorelin.↗
Added to PeptideScanner November 15, 2026
Source year
2010
Regulatory
Drugs@FDA application NDA022437↗
The official Drugs@FDA dataset lists original submission 1 for NDA 022437 with status AP dated 2010-03-10, and names triptorelin pamoate among the application record's active ingredients.↗
Added to PeptideScanner November 15, 2026
Source year
2001
Regulatory
Drugs@FDA application NDA021288↗
The official Drugs@FDA dataset lists original submission 1 for NDA 021288 with status AP dated 2001-06-29, and names triptorelin pamoate among the application record's active ingredients.↗
Added to PeptideScanner November 15, 2026
Source year
2000
Regulatory
Drugs@FDA application NDA020715↗
The official Drugs@FDA dataset lists original submission 1 for NDA 020715 with status AP dated 2000-06-15, and names triptorelin pamoate among the application record's active ingredients.↗
Added to PeptideScanner November 15, 2026